Navigating Swiss Market Access #medtech #digitalhealth
Navigating Swiss Market Access #medtech #digitalhealth
Podcast Description
Reimbursement of Digital Health TechnologiesExploring, understanding, uncovering strategies & tactics to enhance Swiss market access (reimbursement) including MedTech & Medical Devices. Co-hosted by Gurmit Sandhu, AI Practitioner in Healthcare & Angelina Rau, Attorney at Law | Switzerland.
Podcast Insights
Content Themes
Focuses on strategies for reimbursement of digital health technologies, MedTech, and medical devices, with episodes discussing research journeys, regulatory insights, and challenges faced by stakeholders in Switzerland's digital health ecosystem.

Reimbursement of Digital Health Technologies
Exploring, understanding, uncovering strategies & tactics to enhance Swiss market access (reimbursement) including MedTech & Medical Devices.
Co-hosted by Gurmit Sandhu, AI Practitioner in Healthcare & Angelina Rau, Attorney at Law | Switzerland.
In this episode (in Swiss German), host Angelina Rau sits down with Barbara Meier, attorney at law at VISCHER AG and expert in tariff and healthcare law, to unpack one of the most complex yet crucial topics for digital health innovators in Switzerland — reimbursement and tariffs.
They discuss how Digital Health Applications (DiGAs) — software-based medical devices such as health apps or digital therapeutics — gain access to the Swiss healthcare system. Even when approved and recognized under compulsory health insurance (OKP), a DiGA can only be reimbursed if it fits into an appropriate reimbursement and tariff structure.
Barbara explains Switzerland’s three main reimbursement “categories”:
- Hospitals, inpatient and outpatient tariffs (like TARMED and the upcoming TARDOC) for services delivered by healthcare professionals,
- and the MiGeL list, covering DiGAs provided directly to patients.
Together, they explore how upcoming reforms, such as TARDOC, aim to modernize reimbursement for telemedicine and digital care — and why early collaboration between manufacturers and healthcare providers is essential for success.
Whether you’re a startup founder, digital health manufacturer, or health policy professional, this episode offers clear insights on how to navigate tariff systems, secure reimbursement, and bring innovation into the Swiss healthcare landscape.
GET IN TOUCH:
Feedback? We’re listening. Send us a message on LinkedIn:
https://linkedin.com/in/gurmitsandhu | https://linkedin.com/in/angelina-rau
Share your experience, feedback, “pain points” or success with market access & reimbursement of digital health technology #medtech #meddevice :
on the comments section below or DM us on LinkedIn
Do you know someone who would be a great guest for us to interview? Let us know via LinkedIn| Topics that you want us to focus on. Drop us a comment below!
What to Read:
Reimbursement guide on digital health applications within the Swiss healthcare system | Created in collaboration with experts in insurance, law, pharma, and industry including Angelina Rau | Free access, in Eng & De =>
https://swisshealthcarestartups.com/en/reimbursement-guide
Kohler, Stefan / Rau, Angelina, Vergütung digitaler Gesundheitsanwendungen in der Schweiz, Life Sciences Recht Stämpfli, LSR 1/2023, S. 13-22, Januar 2023
Sandhu G, Mohamed Ghazali IM, Laurenzi E, Miho E. PP22 A Dashboard To Support The Value Assessment Of Digital Health Technologies For H…

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.